Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The interface between COVID-19 and bacterial healthcare-associated infections
Ronan O’Toole
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 12, pp. 1772-1776
Open Access | Times Cited: 156

Showing 1-25 of 156 citing articles:

Impact of COVID-19 on Antimicrobial Consumption and Spread of Multidrug-Resistance in Bacterial Infections
Kibum Jeon, Seri Jeong, Nuri Lee, et al.
Antibiotics (2022) Vol. 11, Iss. 4, pp. 535-535
Open Access | Times Cited: 71
Increased Detection of Carbapenemase-Producing Enterobacterales Bacteria in Latin America and the Caribbean during the COVID-19 Pandemic
Genara Romero Thomas, Alejandra Corso, Fernando Pasterán, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 11, pp. 1-8
Open Access | Times Cited: 65
Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study
Niccolò Buetti, Alexis Tabah, Ambre Loiodice, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 40
ESKAPE and Beyond: The Burden of Coinfections in the COVID-19 Pandemic
Miguel Ángel Loyola-Cruz, Luis Uriel Gonzalez-Avila, Arturo Martínez-Trejo, et al.
Pathogens (2023) Vol. 12, Iss. 5, pp. 743-743
Open Access | Times Cited: 31
Antibiotic Heteroresistance in Klebsiella pneumoniae
Karolina Stojowska‐Swędrzyńska, Adrianna Łupkowska, Dorota Kuczyńska‐Wiśnik, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 449-449
Open Access | Times Cited: 40
Large increase in bloodstream infections with carbapenem-resistant Acinetobacter species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021
Pete Kinross, Carlo Gagliotti, Hanna Merk, et al.
Eurosurveillance (2022) Vol. 27, Iss. 46
Open Access | Times Cited: 32
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015–2021)
Marianna Meschiari, Lorenzo Onorato, Erica Bacca, et al.
Antibiotics (2022) Vol. 11, Iss. 6, pp. 826-826
Open Access | Times Cited: 31
Antimicrobial Resistance of Staphylococcus aureus Isolated between 2017 and 2022 from Infections at a Tertiary Care Hospital in Romania
Daniela Tălăpan, Andreea-Mihaela Sandu, Alexandru Rafilă
Antibiotics (2023) Vol. 12, Iss. 6, pp. 974-974
Open Access | Times Cited: 18
Antimicrobial Efficacy of Argon Cold Atmospheric Pressure Plasma Jet on Clinical Isolates of Multidrug-Resistant ESKAPE Bacteria
Sarthak Das, G. Veda Prakash, Sarita Mohapatra, et al.
IEEE Transactions on Radiation and Plasma Medical Sciences (2023) Vol. 7, Iss. 4, pp. 421-428
Open Access | Times Cited: 17
Emerging Antimicrobial Resistance
Cynthia E. Flynn, Jeannette Guarner
Modern Pathology (2023) Vol. 36, Iss. 9, pp. 100249-100249
Closed Access | Times Cited: 17
Epidemiological Analysis of a K. pneumoniae NDM Outbreak in a Temporary Ward for Patients with Primary COVID-19 Infection
Agata Pruss, Klaudia Miładowska, Helena Masiuk, et al.
Microbiology Research (2025) Vol. 16, Iss. 1, pp. 17-17
Open Access
The impact of COVID-19 pandemic on nosocomial infections in the cardiac care unit of a non-epidemic hospital in China
Xiang Liao, Wei Wu, Lijuan Zhang, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Phage therapy in the management of respiratory and pulmonary infections: a systematic review
Patience Sarkodie-Addo, Abdul-Halim Osman, Bill Clinton Aglomasa, et al.
Therapeutic Advances in Infectious Disease (2025) Vol. 12
Open Access
Sodium ibuprofenate: antibacterial activities and potential β-lactamase inhibition in critical Gram-negative bacteria
Franco Antonio Manzanelli, Camila M. Clemente, Luciana P. Campagno, et al.
Future Microbiology (2025), pp. 1-13
Closed Access
COVID-19: Impact on prescribing and antimicrobial resistance
Patrícia Ruíz-Garbajosa, Rafael Cantón
Revista Española de Quimioterapia (2021) Vol. 34, Iss. Suppl 1, pp. 63-68
Open Access | Times Cited: 33
Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study
David R. Smith, George Shirreff, Laura Temime, et al.
PLoS Medicine (2023) Vol. 20, Iss. 6, pp. e1004240-e1004240
Open Access | Times Cited: 14
The Clash of the Titans: COVID-19, Carbapenem-Resistant Enterobacterales, and First mcr-1-Mediated Colistin Resistance in Humans in Romania
Ionela-Larisa Miftode, Daniela Leca, Radu-Ștefan Miftode, et al.
Antibiotics (2023) Vol. 12, Iss. 2, pp. 324-324
Open Access | Times Cited: 13
Carbapenem-Resistant Acinetobacter spp Infection in Critically Ill Patients With Limited Treatment Options: A Descriptive Study of Cefiderocol Therapy During the COVID-19 Pandemic
Maddalena Giannella, Stefano Verardi, Andreas Karas, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 7
Open Access | Times Cited: 13
Antibiotic resistance and consumption before and during the COVID-19 pandemic in Valle del Cauca, Colombia
Isabel Cristina Hurtado, Sandra Inés Aguirre Valencia, Elisa María Pinzón, et al.
Revista Panamericana de Salud Pública (2023) Vol. 47, pp. 1-1
Open Access | Times Cited: 12
Prevalence and Impact on Mortality of Colonization and Super-Infection by Carbapenem-Resistant Gram-Negative Organisms in COVID-19 Hospitalized Patients
Roberto Casale, Gabriele Bianco, Paulo Bastos, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1934-1934
Open Access | Times Cited: 12
Clinical and microbiological profile of health care–associated infections in a tertiary hospital: Comparison between a cohort of hospitalized patients during prepandemic and COVID-19 pandemic periods
Youssef H. Ismael, Henrique G. Pacheco e Castilho, Felipe Zhen, et al.
American Journal of Infection Control (2024) Vol. 52, Iss. 6, pp. 712-718
Closed Access | Times Cited: 4
An Overview of the Impact of Bacterial Infections and the Associated Mortality Predictors in Patients with COVID-19 Admitted to a Tertiary Center from Eastern Europe
Amalia-Stefana Timpau, Radu-Ștefan Miftode, Irina‐Iuliana Costache, et al.
Antibiotics (2023) Vol. 12, Iss. 1, pp. 144-144
Open Access | Times Cited: 11
Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era
Tingting Zhang, Weiwei Tian, Shuang Wei, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Antimicrobial Resistance in Qatar: Prevalence and Trends before and Amidst the COVID-19 Pandemic
Hassan Al Mana, Hamad Abdel Hadi, Godwin Wilson, et al.
Antibiotics (2024) Vol. 13, Iss. 3, pp. 203-203
Open Access | Times Cited: 3
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections
Léo Sauvat, Paul O. Verhoeven, Julie Gagnaire, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 3
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top